59 results
8-K
EX-1.1
IMVT
Immunovant Inc
28 Sep 23
Entry into a Material Definitive Agreement
5:23pm
material respects with the requirements of Rule 433 under the Securities Act, including timely filing with the Commission or retention where required
8-K
EX-1.1
e5y91bv5h8526
4 Oct 22
Immunovant Announces Pricing of $75.0 Million Underwritten Offering of Common Stock
5:28pm
PRE 14A
7x8pn
2 Aug 21
Preliminary proxy
4:31pm
424B3
kh0500y4115jg5l70z
12 Nov 20
Prospectus supplement
8:32am